EN
HI
Cohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
1.25 CR
Market Cap
18487.56 CR
LTQ@LTP
908@483.25
ATP
479.04
Var Margin
50 %
Circuit Range
374.05-561.05
Delivery %
10.67 %
Value
598.19 CR
ASM/GSM
No
Market Lot
1
Summary
Cohance Lifesciences share price stands at ₹483.25 at 30 Apr, 2026 | 15:59. The stock Cohance Lifesciences intraday movement has stayed between ₹442.60 and ₹498.80, while on a 52-week basis it has fluctuated from ₹266.70 to ₹1235.00.
In terms of trading activity, Cohance Lifesciences has recorded a volume of 12487304 shares. The Cohance Lifesciences has a market cap of ₹382567140. The stock’s Average Traded Price (ATP) stands at ₹47904, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 908, 48325.
The Cohance Lifesciences operates within a circuit range of ₹374.05-561.05 – ₹374.05-561.05, with a Value of ₹598.19 CR. The Delivery Percentage for the day is 10.67%. Additionally, Cohance Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Cohance Lifesciences Fundamentals
View MoreP/E Ratio
91.61
P/B Ratio
4.84
Div. Yield
0
Sector P/E
65.48
Sector P/B
3.5
Sec. Div. Yield
0.57
Cohance Lifesciences Resistance and Support
Pivot 474.88
Resistance
First Resistance
507.16
Second Resistance
531.08
Third Resistance
563.36
Support
First Support
450.96
Second Support
418.68
Third Support
394.76
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences shares need to cross this level to recover all the losses for 2026
Cohance Lifesciences shares are noted to require crossing the ₹118.5 level to recover 2026 losses, following a recent price fluctuation from ₹100 to ₹130 and subsequent retracement. Technical analysis suggests ₹118.5 is a key resistance for a rebound, with a support level identified at ₹99.
Apr 28 2026 11:04:00
Cohance Lifesciences Limited
Vivek Sharma has resigned as Cohance Lifesciences' Executive Chairman and Director, effective April 30, 2026. The departure is due to personal reasons, as stated in his letter.
Apr 27 2026 20:04:00
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Vivek Sharma | Chairman |
| Himanshu Agarwal | Whole Time Director |
Cohance Lifesciences Similar Stocks
Onesource Specialty Pharma Ltd.
1738.10
0.00 (0.00%)
Natco Pharma Ltd.
1095.75
0.00 (0.00%)
Astrazeneca Pharma India Ltd.
8213.00
0.00 (0.00%)
Neuland Laboratories Ltd.
15003.00
0.00 (0.00%)
Eris Lifesciences Ltd.
1322.90
0.00 (0.00%)
Granules India Ltd.
699.70
0.00 (0.00%)
Poly Medicure Ltd.
1512.10
0.00 (0.00%)
Alembic Pharmaceuticals Ltd.
755.00
0.00 (0.00%)
Jubilant Pharmova Ltd.
926.60
0.00 (0.00%)
Dr. Agarwal's Health Care Ltd.
445.10
0.00 (0.00%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 483.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 91.61. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.84. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 65.48 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 18487.56 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1235.00 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
